Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
CAMBRIDGE MOLECULAR DIAGNOSTICS LTD
Active- 09600771Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 25 Science Park, Bio-Innovation Centre, Milton Road, Cambridge CB4 0FW
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 25/06/2026View PDF (9 pages)
Total exemption full accounts made up to 2025-12-31
- 12/02/2026View PDF (36 pages)
Registration of charge 096007710001, created on 2026-01-30
- 10/02/2026View PDF (1 pages)
Termination of appointment of Benjamin Fraser Adam Shaw as a director on 2025-11-01
- 10/02/2026View PDF (1 pages)
Termination of appointment of Gustavo Andrés Cerda Moya as a director on 2025-12-11
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 17/02/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures CAMBRIDGE MOLECULAR DIAGNOSTICS LTD filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£2.29M2024
168.19%vs 20232023: £855.64K
Total Assets
£2.68M2024
58.75%vs 20232023: £1.69M
Cash in Bank
£39.98K2024
-77.36%vs 20232023: £176.60K
Total Liabilities
£357.62K2024
-54.49%vs 20232023: £785.73K
Employees
62024
-2vs 20232023: 8
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Net assets moved furthest, up 168.19% on 2023. See the full financial analysis for CAMBRIDGE MOLECULAR DIAGNOSTICS LTD.
The full financial record
Four ways through CAMBRIDGE MOLECULAR DIAGNOSTICS LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +115% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 6 | -2 |
| 2023 | 8 | +1 |
| 2022 | 7 | +2 |
| 2021 | 5 | – |
Reported employee count increased from 5 in 2021 to 6 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
9Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 14/09/2018–06/02/2023 | 5 | |
| Corporate Director | 14/09/2018–04/06/2024 | 4 | |
| Director | 04/06/2015–27/11/2015 | 8 | |
| Director | 04/06/2015–27/11/2015 | 35 | |
| Director | 20/06/2022–Present | 16 | |
| Director | 14/09/2018–06/02/2023 | 13 | |
| Director | 20/05/2015–11/12/2025 | 1 | |
| Corporate Director | 04/06/2024–Present | 0 | |
| Director | 10/03/2016–01/11/2025 | 0 |
Persons with significant control
1Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 75 Since 20/05/2015
- Last 12 months
- 5 Same as the year before (5)
- Most recent filing
- 25/06/2026 3 months ago
What changed in the last year
- Accounts filedLatest 25/06/2026
- Charges and mortgagesLatest 12/02/2026
- Officer changes (2)Latest 10/02/2026
- Share capitalLatest 25/11/2025
Filing timeline
- 25/06/2026View PDF (9 pages)
Total exemption full accounts made up to 2025-12-31
- 12/02/2026View PDF (36 pages)
Registration of charge 096007710001, created on 2026-01-30
- 10/02/2026View PDF (1 pages)
Termination of appointment of Benjamin Fraser Adam Shaw as a director on 2025-11-01
- 10/02/2026View PDF (1 pages)
Termination of appointment of Gustavo Andrés Cerda Moya as a director on 2025-12-11
- 25/11/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2025-08-21
- 05/06/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2025-02-10
- 17/04/2025View PDF (13 pages)
Total exemption full accounts made up to 2024-12-31
- 24/03/2025View PDF (5 pages)
Confirmation statement made on 2025-02-17 with updates
- 22/01/2025View PDF (1 pages)
Previous accounting period shortened from 2025-01-31 to 2024-12-31
- 07/01/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2024-10-16
- 09/09/2024View PDF (2 pages)
Appointment of Reencara Limited as a director on 2024-06-04
- 09/09/2024View PDF (1 pages)
Termination of appointment of Isosceles Finance Ltd as a director on 2024-06-04
Showing 12 of 75 filings
See when the next accounts and confirmation statement are due
Similar companies
84 UK companies are similar to CAMBRIDGE MOLECULAR DIAGNOSTICS LTD, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
ELIPTICA LIMITED
Active2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
- Activity
- Research and experimental development on biotechnology
- Company no.
- 14041502
- Incorporated
- 12/04/2022
- Employees
- 5
LAMBDA ENERGY LTD
ActiveAllia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11246890
- Incorporated
- 10/03/2018
- Employees
- 5
AKL RESEARCH & DEVELOPMENT LIMITED
ActiveThe Lexicon Second Floor, Mount Street, Manchester M2 5NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 08699350
- Incorporated
- 20/09/2013
- Employees
- 5
ADDIBLE LTD
ActiveSpitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12633636
- Incorporated
- 30/05/2020
- Employees
- 7
AMPERSAND HEALTH LIMITED
Active76 Portland Place, London W1B 1NT
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11584266
- Incorporated
- 24/09/2018
- Employees
- 5
About CAMBRIDGE MOLECULAR DIAGNOSTICS LTD
A short description of the company, written from its Companies House record.
CAMBRIDGE MOLECULAR DIAGNOSTICS LTD is a private limited company registered in the United Kingdom, based in 25 Science Park, Bio-Innovation Centre, Milton Road, Cambridge CB4 0FW. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 11 years 4 months.
The register currently records it as active. Its 2024 accounts report net assets of £2.29M and 6 employees.
CAMBRIDGE MOLECULAR DIAGNOSTICS LTD: frequently asked questions
Answered from this company's own registry record and filed figures.
What does CAMBRIDGE MOLECULAR DIAGNOSTICS LTD do?
Companies House records CAMBRIDGE MOLECULAR DIAGNOSTICS LTD under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is CAMBRIDGE MOLECULAR DIAGNOSTICS LTD still active?
CAMBRIDGE MOLECULAR DIAGNOSTICS LTD is recorded as active on the Companies House register, and has been on it since 20/05/2015.
What are CAMBRIDGE MOLECULAR DIAGNOSTICS LTD's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £2.29M, total assets of £2.68M, cash in bank of £39.98K and total liabilities of £357.62K.
When did CAMBRIDGE MOLECULAR DIAGNOSTICS LTD last file with Companies House?
The most recent document on the record is dated 25/06/2026: Total exemption full accounts made up to 2025-12-31, 3 months ago.
When are CAMBRIDGE MOLECULAR DIAGNOSTICS LTD's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs CAMBRIDGE MOLECULAR DIAGNOSTICS LTD?
Companies House lists 9 officers (2 currently in post) and 1 person with significant control.